Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
NHS, Alzheimer's
NHS will not fund new drug to slow Alzheimer’s
A new drug that slows the pace of
Alzheimer
's disease is too expensive for too little benefit to be used on the
NHS
in England, the drugs spending watchdog says. Donanemab was hailed as a turning point in the disease last year. But the National Institute ...
Alzheimer’s wonder drug blocked on NHS over cost
The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for the disease safe for use but the rationing body has immediately ruled that it is too expensive for NHS patients.
Alzheimer’s drug rejected for widespread use by NHS spending watchdog
A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”.The news comes as the UK’s medicines regulator said donanemab could be licensed for use in the UK.
Sky News on MSN
15h
Pioneering Alzheimer's drug rejected for widespread use in NHS in England
A new pioneering Alzheimer's drug has been rejected for widespread use in the NHS in England. The announcement comes as the ...
1d
on MSN
Why thousands of dementia sufferers are being denied the new miracle drug
In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback